2020 COVID-19 Vaccine Public Health 
Bill of Health
NOVEMBER 8, 2022
In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. appeared first on Bill of Health. By Sarah Gabriele.
Bill of Health
JANUARY 12, 2023
In October 2020, Moderna pledged not to enforce its patents amid the ongoing pandemic. Indeed, as made public, the U.S. government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines. Moderna has since made over $30 billion in COVID-19 vaccine sales.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
NOVEMBER 2, 2023
By Rossella De Falco Strong, well-coordinated and resilient public health care services play a vital role in preventing and responding to public health crises. A range of UN Human Rights Treaty Bodies have further contributed to interpret the human rights implications of private actors’ involvement in health care.
Bill of Health
NOVEMBER 14, 2023
By Eduardo Arenas Catalán The Principles and Guidelines on Human Rights and Public Health Emergencies (the Principles), entail a notable attempt to consolidate lessons learned from the COVID-19 pandemic. The critical notion of shared but differentiated responsibilities is thus strengthened within global public health.
Bill of Health
SEPTEMBER 20, 2022
By December 2020, the world had astonishingly powerful tools against COVID-19. New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators. The answer to one of the most important public health questions of our time — who gets access to vaccines? —
Bill of Health
NOVEMBER 21, 2023
By Zione Ntaba Malawi is not a stranger to public health crises in the last number of years, having faced a severe HIV epidemic and several cholera outbreaks continuing into 2023. Nevertheless, the onset of the COVID-19 pandemic caused a major panic in the country’s legal system and judiciary.
Bill of Health
AUGUST 29, 2022
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. On October 8, 2020, amid press coverage of an emerging inventorship dispute with the U.S. From 2020 to 2022, the U.S. By Jorge L. Moderna’s Pledge.
Expert insights. Personalized for you.
312 
Let's personalize your content